Yahoo Web Search

Search results

    • KRAS inhibitors: The next frontier beckons

      KRAS inhibitors: The next frontier beckons

      Pharmaceutical Technology via Yahoo Finance· 5 days ago

      Krazati and Lumakras both target KRAS G12C, which is a prominent mutation seen in NSCLC. However, certain cancers such as pancreatic cancer< ...